Atlas Trials

Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery

Clinical trial NCT00333255 · COMPLETED

Trial details

NCT number
NCT00333255
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cataract
Start date
2005-09-01
Primary completion
2006-03-01
Enrollment
267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.